Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9AGY2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 43 | 47 | PF00656 | 0.464 |
CLV_NRD_NRD_1 | 133 | 135 | PF00675 | 0.544 |
CLV_NRD_NRD_1 | 82 | 84 | PF00675 | 0.568 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.541 |
CLV_PCSK_KEX2_1 | 133 | 135 | PF00082 | 0.511 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.675 |
CLV_PCSK_PC1ET2_1 | 88 | 90 | PF00082 | 0.675 |
CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.518 |
DOC_CYCLIN_yCln2_LP_2 | 109 | 112 | PF00134 | 0.633 |
DOC_MAPK_gen_1 | 83 | 93 | PF00069 | 0.574 |
DOC_MAPK_MEF2A_6 | 18 | 26 | PF00069 | 0.496 |
DOC_PP2B_LxvP_1 | 109 | 112 | PF13499 | 0.559 |
DOC_PP4_FxxP_1 | 108 | 111 | PF00568 | 0.759 |
DOC_PP4_FxxP_1 | 127 | 130 | PF00568 | 0.459 |
DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.530 |
DOC_USP7_UBL2_3 | 84 | 88 | PF12436 | 0.547 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.517 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.623 |
LIG_14-3-3_CanoR_1 | 40 | 46 | PF00244 | 0.531 |
LIG_APCC_ABBAyCdc20_2 | 123 | 129 | PF00400 | 0.428 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.678 |
LIG_BRCT_BRCA1_1 | 104 | 108 | PF00533 | 0.542 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.555 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.470 |
LIG_FHA_2 | 111 | 117 | PF00498 | 0.579 |
LIG_LIR_Apic_2 | 105 | 111 | PF02991 | 0.563 |
LIG_LIR_Nem_3 | 33 | 38 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.488 |
LIG_LYPXL_SIV_4 | 37 | 45 | PF13949 | 0.525 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.448 |
LIG_SH2_STAP1 | 78 | 82 | PF00017 | 0.539 |
LIG_SH2_STAT3 | 49 | 52 | PF00017 | 0.522 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.577 |
LIG_SH2_STAT5 | 81 | 84 | PF00017 | 0.511 |
LIG_SH3_2 | 7 | 12 | PF14604 | 0.459 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.519 |
LIG_SH3_3 | 79 | 85 | PF00018 | 0.542 |
LIG_SH3_4 | 84 | 91 | PF00018 | 0.621 |
LIG_SUMO_SIM_par_1 | 22 | 28 | PF11976 | 0.516 |
LIG_TYR_ITIM | 36 | 41 | PF00017 | 0.456 |
MOD_CK1_1 | 28 | 34 | PF00069 | 0.627 |
MOD_CK2_1 | 94 | 100 | PF00069 | 0.591 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.608 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.517 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.531 |
MOD_PIKK_1 | 110 | 116 | PF00454 | 0.585 |
MOD_PIKK_1 | 60 | 66 | PF00454 | 0.529 |
MOD_PKA_1 | 83 | 89 | PF00069 | 0.587 |
MOD_PKA_2 | 68 | 74 | PF00069 | 0.568 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.488 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.511 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.624 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.455 |
TRG_ER_diArg_1 | 133 | 135 | PF00400 | 0.510 |
TRG_NLS_MonoExtN_4 | 84 | 91 | PF00514 | 0.563 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HS75 | Leptomonas seymouri | 80% | 99% |
A0A1X0NT17 | Trypanosomatidae | 56% | 100% |
A0A3S7WWV6 | Leishmania donovani | 100% | 100% |
A0A422MUD0 | Trypanosoma rangeli | 47% | 100% |
A4HC53 | Leishmania braziliensis | 83% | 100% |
E9AVI7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QBZ2 | Leishmania major | 88% | 100% |